| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
| 01/10/2006 | CA2383332C Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 01/05/2006 | WO2006001894A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/05/2006 | WO2004091504A3 Substituted quinobenzoxazine analogs |
| 01/05/2006 | US20060004082 6H-thieno'2, 3-b!pyrrole derivatives as antagonists of gonadotropin releasing hormone (gnrh) |
| 01/05/2006 | US20060004053 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| 01/05/2006 | US20060004052 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy |
| 01/05/2006 | US20060004038 Novel compounds |
| 01/05/2006 | US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 01/05/2006 | US20060004009 Ethylenediamine derivatives |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003978 beta-secretase inhibitors; to reduce A beta peptide formation; to reduce amyloid beta deposits or plaques; 12-[2-(3-Ethyl-benzylamino)-1-hydroxy-ethyl]-16-fluoro-2-oxa-8,11-diaza-bicyclo[12.3.1]octadeca-1(17),14(18),15-triene-7,10-dione |
| 01/05/2006 | DE102004029774A1 New 3,4-alkylenedioxy-2,5-dialkoxy-tetrahydrofuran and/or 3,4-arylendioxy-2,5-dialkoxy-tetrahydrofuran compounds useful for preparing e.g. 3,4-alkylenedioxythiophene and/or 3,4-arylenedioxythiophene and 3,4-alkylenedioxyselenophene |
| 01/05/2006 | CA2567977A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/04/2006 | EP1611139A1 Methods of preparing olanzapine |
| 01/04/2006 | EP1611096A2 Benzamide modulators of metabotropic glutamate receptors |
| 01/04/2006 | EP1610759A2 Substituted quinobenzoxazine analogs |
| 01/04/2006 | EP1383741A4 Process for the preparation of benazepril |
| 01/04/2006 | EP1102755B1 Substituted isoxazole derivatives as estrogen receptor modulators |
| 01/04/2006 | CN1715280A Aryl fused azapolycyclic compounds |
| 01/03/2006 | US6982261 A progesterone receptor antagonist for providing progestational therapy, treating cancer of breast, uterine, ovarian, endometrial, or prostate, providing contraceptives, hormone replacement therapy |
| 01/03/2006 | CA2359476C Hypolipidemic and antioxidant morpholine derivatives |
| 12/29/2005 | WO2005123748A1 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 12/29/2005 | WO2005123747A1 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 12/29/2005 | WO2005123746A1 Methods for preparation of levofloxacin and ofloxacin |
| 12/29/2005 | WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 12/29/2005 | WO2005123087A2 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| 12/29/2005 | WO2005122768A1 Substituted benzoylpyrazoles used as herbicides |
| 12/29/2005 | WO2005062882A3 Rifamycin analogs and uses thereof |
| 12/29/2005 | WO2005051974A3 Novel molecules for regulating cell death |
| 12/29/2005 | WO2005012294A8 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 12/29/2005 | US20050288336 Cysteine protease inhibitors |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/29/2005 | US20050288273 Antibacterial agents |
| 12/29/2005 | US20050288269 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| 12/29/2005 | DE102004029308A1 Substituierte Benzoylpyrazole als Herbiszide Substituted benzoylpyrazoles as Herbiszide |
| 12/29/2005 | CA2569308A1 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 12/29/2005 | CA2568895A1 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 12/29/2005 | CA2568379A1 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| 12/28/2005 | EP1608648A1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 12/28/2005 | EP1608632A1 Quinazolines useful as modulators of ion channels |
| 12/28/2005 | EP1608631A2 Bi-cyclic pyrimidine inhibitors of tgf beta |
| 12/28/2005 | EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 12/28/2005 | EP1414438B1 Antineoplastic combinations |
| 12/28/2005 | CN1714093A Diazinopyrimidines |
| 12/28/2005 | CN1713908A Aminoalkoxyindoles as 5-HT6-receptor ligands for the treatment of CNA-disorders |
| 12/27/2005 | US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 12/22/2005 | WO2005121327A2 Biosynthetic gene cluster for the production of a complex polyketide |
| 12/22/2005 | WO2005121153A1 Condensed pyrimidine derivative and xanthine oxidase inhibitor |
| 12/22/2005 | WO2005121152A1 Substituted triazole derivatives as oxytocin antagonists |
| 12/22/2005 | WO2005121151A2 Thienopyridinone compounds and methods of treatment |
| 12/22/2005 | WO2005121138A2 Heterotricyclic compounds for use as hcv inhibitors |
| 12/22/2005 | WO2005121137A1 Asymmetric michael and aldol addition using bifunctional cinchona-alkaloid-based catalysts |
| 12/22/2005 | WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 12/22/2005 | WO2005121094A1 Piperazine and piperidine derivatives as anti-hiv-agents |
| 12/22/2005 | WO2005058231A3 Rifamycin analogs and uses thereof |
| 12/22/2005 | US20050282863 Novel-N substituted dihydrobenzothiepino, dihydrobenzoxepino and tetrahydro benzocyclohepta indoles as selective estrogen receptor modulators |
| 12/22/2005 | US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 12/22/2005 | US20050282851 antidiabetic agents such as 3-Cyclopentyl-2-(4-methanesulfonyl-phenyl)-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-propionamide, used for prevention and treatment of impaired glucose tolerance, non-insulin dependent diabetes and obesity |
| 12/22/2005 | US20050282850 Tetrazolo[1,5-a]thieno[2,3-e]pyridine-4-carboxylic acid |
| 12/22/2005 | US20050282796 Tetracyclic azepinoindole compounds |
| 12/22/2005 | US20050282709 Substituted benzoylpyrazoles as herbicides |
| 12/22/2005 | CA2570046A1 Substituted triazole derivatives as oxytocin antagonists |
| 12/22/2005 | CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 12/22/2005 | CA2567268A1 Thienopyridinone compounds and methods of treatment |
| 12/22/2005 | CA2567043A1 Biosynthetic gene cluster for the production of a complex polyketide |
| 12/21/2005 | EP1606292A2 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications |
| 12/21/2005 | EP1606254A1 2,4,6-phenyl substituted cyclic ketoenols |
| 12/21/2005 | EP1605938A2 Antibacterial agents |
| 12/21/2005 | EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 12/21/2005 | EP1313738B1 Process for the preparation and purification of thiol-containing maytansinoids |
| 12/21/2005 | CN1232508C Cyclization process step in making of quinolones and phenodiazine |
| 12/20/2005 | CA2159481C Tetracyclic compounds as dopamine agonists |
| 12/15/2005 | WO2005118594A1 Muscarinic acetylcholine receptor antagonists |
| 12/15/2005 | WO2005118593A1 Bicyclic heterocycles as hiv integrase inhibitors |
| 12/15/2005 | WO2005118549A2 Compounds having affinity for dopamine d3 receptor and uses thereof |
| 12/15/2005 | WO2005117986A2 Antibody drug conjugates and methods |
| 12/15/2005 | WO2005117837A1 Process for preparation of amorphous form of a drug |
| 12/15/2005 | US20050277654 4,5-Disubstituted-2-aryl pyrimidines |
| 12/15/2005 | US20050277636 Lowering intraocular pressure with S)-2-(8,9-dihydro-9-methyl-7H-[1,4]oxazino[2,3-g]indazol-1-yl)-1-methylethylamine fumarate |
| 12/15/2005 | US20050277630 Antibacterial agents |
| 12/15/2005 | US20050276812 Antibody-drug conjugates and methods |
| 12/15/2005 | CA2568213A1 Composition and method for the treatment of tauopathies |
| 12/15/2005 | CA2567520A1 Maytansinoid-antibody conjugates |
| 12/15/2005 | CA2560984A1 Process for preparation of amorphous form of a drug |
| 12/14/2005 | EP1603901A1 Tetrahydropyran compounds as tachykinin antagonists |
| 12/14/2005 | EP1603567A2 Tetracyclic benzamide derivatives and methods of use thereof |
| 12/14/2005 | EP1603557A2 Synthesis of peloruside a and analogs thereof for use as antitumor agents |
| 12/14/2005 | EP1427709B1 3-substituted-4-pyrimidone derivatives |
| 12/14/2005 | EP1326858B1 Piperidine compounds as anti-allergic |
| 12/14/2005 | CN1231461C Bicyclo [2.2.1] heptanes and related compounds |
| 12/08/2005 | WO2005117242A1 Method and installation means for installing an electrical machine |
| 12/08/2005 | WO2005116014A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
| 12/08/2005 | WO2005115986A1 Therapeutic compounds: pyridine as scaffold |
| 12/08/2005 | WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists |
| 12/08/2005 | WO2005115398A2 Hiv integrase inhibitors |
| 12/08/2005 | WO2005090294A3 PROCESS OF MAKING α-AMINOOXYKETONE/α-AMINOOXYALDEHYDE AND α-HYDROXYKETONE/α-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS OF MAKING REACTION PRODUCTS FROM CYCLIC α,ß-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES |
| 12/08/2005 | WO2005077932A3 Chemokine receptor antagonists |
| 12/08/2005 | WO2005009384A3 Egfr tyrosine kinase inhibitors |